scispace - formally typeset
F

Faruk Ahmed

Researcher at Griffith University

Publications -  115
Citations -  11412

Faruk Ahmed is an academic researcher from Griffith University. The author has contributed to research in topics: Population & Vitamin. The author has an hindex of 34, co-authored 108 publications receiving 10814 citations. Previous affiliations of Faruk Ahmed include University of Southampton & University of Queensland.

Papers
More filters
Posted Content

Improved Training of Wasserstein GANs

TL;DR: This work proposes an alternative to clipping weights: penalize the norm of gradient of the critic with respect to its input, which performs better than standard WGAN and enables stable training of a wide variety of GAN architectures with almost no hyperparameter tuning.
Proceedings Article

Improved training of wasserstein GANs

TL;DR: The authors proposed to penalize the norm of the gradient of the critic with respect to its input to improve the training stability of Wasserstein GANs and achieve stable training of a wide variety of GAN architectures with almost no hyperparameter tuning.
Posted Content

PixelVAE: A Latent Variable Model for Natural Images

TL;DR: PixelVAE as mentioned in this paper is a VAE model with an autoregressive decoder based on PixelCNN, which achieves state-of-the-art performance on binarized MNIST, competitive performance on 64x64 ImageNet, and high quality samples on the LSUN bedrooms dataset.
Proceedings Article

Reducing Overfitting in Deep Networks by Decorrelating Representations

TL;DR: DeCov as mentioned in this paper encourages diverse or non-redundant representations in deep neural networks by minimizing the cross-covariance of hidden activations, which leads to significantly reduced overfitting and better generalization.
Journal ArticleDOI

Prevalence of Cardiovascular Disease and Associated Risk Factors among Adult Population in the Gulf Region: A Systematic Review

TL;DR: Effective preventative strategies and education programs are crucial in the Gulf region to reduce the risk of CVD mortality and morbidity in the coming years.